Medicine and Health Sciences Commons^™

Cost Effective Treatment Options For Uninsured Patients With Diabetes, Sidney Selva, Ryan Bialaszewski, Elizabeth Althaus, Pamela Campos, Shuaibahmed M. Arab, Chelsea Chang

Research Symposium

Background: Approximately 37.3 million people in the United States have diabetes, accounting for 14.7% of the US population. Additionally, an estimated 2 million adults with diabetes have no health insurance coverage, which can contribute to chronic co-morbidities and increase all-cause mortality. Given the economic challenges these uninsured patients may face, it is important for healthcare providers to understand the cost-effective treatment options available to improve long-term outcomes. Therefore, this abstract aims to provide a cost-effective treatment algorithm for uninsured patients with diabetes.

Case Presentation: Our patient was a 47-year-old uninsured Hispanic female with uncontrolled type 2 diabetes mellitus. The …

Project: Center For Diabetes And Metabolism [Centro De Diabetes Y Metabolismo: Cedimet], A Collaborative Dream Comes True, Claudia Munguia-Cisneros, Edith Cantu, Carlos Ramirez-Pfeiffer, Adriana L. Perales-Torres, Esperanza M. Garcia-Oropeza, Estrella Y. Martinez-Lopez, Alvaro Diaz-Badillo, Joselin Hernandez-Ruiz, Alberto O. Chavez-Velazquez, Lucia M. Perez-Navarro, Beatriz Tapia, Juan C. Lopez-Alvarenga

Research Symposium

Reynosa urban area has 690,000 inhabitants (384,000 adults >20 years old), 35% moved from other states. The use of cell phones is in 81%, personal computer or laptop with 29%. The prevalence of overweight is 39%, obesity 36%, and T2D 13%. The expected adult population with T2D is 49,900 individuals. The are 5 clinics prepared to attend T2D, and few with specialized personnel.

The CeDiMet is a collaborative clinic involving health personnel and researchers from the Universidad Mexico Americana del Norte, Universidad Autonoma de Tamaulipas, Hospital General de Mexico “Dr. Eduardo Liceaga”, University of Texas Rio Grande Valley, and the …

Covid-19 And Chronic Diabetes: The Perfect Storm For Reactivation Tb?, Genesis P. Aguillón-Durán, Ericka Prieto-Martinez, Doris Ayala, Juan Garcia Jr, John M. Thomas, Juan I. Garcia, Jordi B. Torrelles, Eder Ledezma-Campos, Blanca I. Restrepo

Research Symposium

Background: The Coronavirus disease 2019 (COVID-19) pandemic is predicted to have a net negative effect on tuberculosis (TB) control, with an estimated excess of 6.3 million tuberculosis cases and 1.4 million deaths by 2025. Programmatic issues like the lockdown of TB services affect all patients, while biosocial factors have a differential impact on an individual’s risk for TB or adverse TB outcomes.

Case presentation: We report three cases of incident TB after resolution of COVID-19 episodes.Coincidently, all cases shared a common risk factor: a chronic history poorly-controlled diabetes.

Conclusions: Our findings alert to the threat posed by …

Barriers To Applying Guidelines For Treatment Of Type 2 Diabetes Mellitus In The Rio Grande Valley, Carra G. Honderich, Chelsea Chang

Research Symposium

Background: Type 2 Diabetes Mellitus affects 29.6% of adults in the Rio Grande Valley and 54% are estimated to be uncontrolled. Established and new pharmacotherapy agents are available, and guidelines exist in individualization of glycemic targets and agent selection. We present a case facing various barriers in applying these guidelines.

Case Presentation: A 54-year-old uninsured woman with past medical history of uncontrolled type 2 diabetes mellitus, hypertension, chronic kidney disease stage 3, peripheral artery disease and bilateral below knee amputations presents for follow-up. She denies polyuria, polydipsia and weight changes. She reports compliance with medications and a fasting glucose range …